Response Evaluation Criteria in Cancer of the Liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 Revised Version)

Hepatology Research : the Official Journal of the Japan Society of Hepatology
Masatoshi KudoLiver Cancer Study Group of Japan (Committee for Response Evaluation Criteria in Cancer of the Liver, Liver Cancer Study Gro

Abstract

The World Health Organization (WHO) criteria and Response Evaluation Criteria in Solid Tumors (RECIST) are inappropriate to assess the direct effects of treatment on the hepatocellular carcinoma (HCC) by locoreginal therapies such as radiofrequency ablation (RFA) and transcatheter arterial chemoembolization (TACE). Therefore, establishment of response evaluation criteria solely devoted for HCC is needed urgently in the clinical practice as well as in the clinical trials of HCC treatment, such as molecular targeted therapies, which cause necrosis of the tumor. Response Evaluation Criteria in Cancer of the Liver (RECICL) was revised in 2009 by Liver Cancer Study Group of Japan based on the 2004 version of RECICL, which was commonly used in Japan. Major revised points of the RECICL 2009 is to provide TE4a (Complete response with enough ablative margin) and TE4b (complete response without enough ablative margin) for local ablation therapy. Second revised point is that setting the timing at which the overall treatment effects are assessed. Third point is that emergence of new lesion in the liver is regarded as progressive disease, different from 2004 version. Finally, 3 tumor markers including alpha-fetoprotein (AFP) and AFP-L3 and ...Continue Reading

References

Mar 24, 1999·Journal of the National Cancer Institute·K JamesP Therasse
Feb 3, 2000·Journal of the National Cancer Institute·E A Gehan, M C Tefft
Feb 20, 2003·Journal of Hepatology·Josep M Llovet, Michel Beaugrand
Nov 19, 2003·Japanese Journal of Clinical Oncology·Joon Oh ParkKeunchil Park
May 15, 2008·Journal of the National Cancer Institute·Josep M LlovetUNKNOWN Panel of Experts in HCC-Design Clinical Trials

❮ Previous
Next ❯

Citations

Jun 29, 2013·Abdominal Imaging·Yang GuoFrank H Miller
Aug 10, 2012·Clinical Drug Investigation·Norihiro KokudoKazushi Numata
Aug 5, 2014·Magnetic Resonance Imaging Clinics of North America·Celia Pamela Corona-VillalobosIhab R Kamel
Oct 11, 2013·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Fernanda D Gonzalez-GuindaliniVahid Yaghmai
Dec 21, 2011·Journal of Gastroenterology·Kenya YamanakaShinji Uemoto
Jun 5, 2015·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Masatoshi KudoUNKNOWN Liver Cancer Study Group of Japan
May 1, 2015·International Journal of Molecular Sciences·Kenji ImaiMasahito Shimizu
Dec 3, 2011·International Journal of Hepatology·L BarbierB Suc
Aug 21, 2012·Radiología·J Cervera Deval
Jan 18, 2012·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Atsuya TakedaAkitomo Sugawara
Jan 30, 2013·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Tomoki KimuraYasushi Nagata
Jul 9, 2011·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Jeong Min LeeChristoph Wald
May 10, 2012·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Shuichi KanekoYukinori Imai
Dec 12, 2012·Journal of Gastroenterology and Hepatology·Yohji HondaKazuaki Chayama
Apr 24, 2013·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Yoshifumi SaitoKoichi Tokuuye
Aug 20, 2015·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Nao KinjoTakeshi Okamura
Sep 28, 2014·Best Practice & Research. Clinical Gastroenterology·Maria ReigJordi Bruix
May 13, 2014·Journal of Gastroenterology·Soichi IritaniHisataka Moriwaki
Mar 13, 2016·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Masatoshi KudoYutaka Matsuyama
Aug 4, 2016·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Kenji IkedaHiromitsu Kumada
Nov 22, 2016·Nihon Hoshasen Gijutsu Gakkai zasshi·Kohei HaradaTatsuya Imai
Apr 25, 2017·Cancer Biomarkers : Section a of Disease Markers·Jian ZhangXiao-Li Zheng
Jan 31, 2018·Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine·Junlin ZhongRongqin Zheng
Dec 28, 2018·AJR. American Journal of Roentgenology·Steven C RoseJafar Golzarian
Nov 21, 2018·The British Journal of Radiology·Virginia B PlanzPerry J Pickhardt
May 3, 2019·Future Oncology·Francesca PatellaBradford J Wood
Jun 25, 2019·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Masatoshi KudoNorihiro Kokudo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.